Cornelis Erik Hack
#178,454
Most Influential Person Now
Cornelis Erik Hack's AcademicInfluence.com Rankings
Cornelis Erik Hackmedical Degrees
Medical
#3689
World Rank
#4186
Historical Rank
Cardiology
#388
World Rank
#400
Historical Rank
Epidemiology
#771
World Rank
#804
Historical Rank
Cornelis Erik Hackphilosophy Degrees
Philosophy
#11059
World Rank
#15189
Historical Rank
Logic
#7872
World Rank
#9793
Historical Rank
Download Badge
Medical Philosophy
Cornelis Erik Hack's Degrees
- Doctorate Medicine University of Amsterdam
- PhD Epidemiology University of Amsterdam
Why Is Cornelis Erik Hack Influential?
(Suggest an Edit or Addition)Cornelis Erik Hack's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? (1999) (882)
- C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. (1997) (412)
- Serum inflammatory proteins and cognitive decline in older persons (2005) (331)
- Inflammatory markers in late-life depression: results from a population-based study. (2008) (313)
- Apoptosis in myocardial ischaemia and infarction (2002) (311)
- Complement activation in amyloid plaques in Alzheimer’s dementia (1988) (301)
- The endothelium in sepsis: Source of and a target for inflammation (2001) (289)
- Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study. (2003) (243)
- A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. (1997) (209)
- Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. (2010) (200)
- Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction (2003) (175)
- Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. (2006) (158)
- Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. (1992) (156)
- Complement-Mediated Ischemia-Reperfusion Injury: Lessons Learned From Animal and Clinical Studies (2009) (151)
- Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. (1994) (143)
- Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. (1994) (137)
- Inflammatory markers in AD and MCI patients with different biomarker profiles (2009) (133)
- C-reactive protein activates complement in infarcted human myocardium. (2003) (121)
- A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. (2005) (119)
- Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction. (2002) (114)
- Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. (1988) (108)
- Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks (2007) (95)
- Generation of plasmin during acute attacks of hereditary angioedema. (1993) (94)
- Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. (1991) (93)
- Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. (2001) (83)
- Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura (1998) (83)
- Bradykinin: Inflammatory Product of the Coagulation System (2016) (80)
- BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. (2010) (76)
- Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis (2004) (75)
- Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia (1995) (73)
- Early complement components in Alzheimer's disease brains (1995) (72)
- Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity (2013) (72)
- Anaphylactic Shock after Insect-Sting Challenge in 138 Persons with a Previous Insect-Sting Reaction (1993) (70)
- Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans. (2002) (68)
- C1-esterase inhibitor substitution in sepsis (1992) (67)
- Clusterin: a protective mediator for ischemic cardiomyocytes? (2005) (67)
- CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls (2007) (67)
- Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C (2012) (67)
- Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis (1997) (66)
- Complement C1-inhibitor expression in Alzheimer’s disease (1998) (66)
- Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. (2006) (62)
- Preliminary report: complement activation in wasp-sting anaphylaxis (1990) (60)
- Epinephrine Exerts Anticoagulant Effects during Human Endotoxemia (1997) (60)
- IgM colocalises with complement and C reactive protein in infarcted human myocardium (2005) (59)
- Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death. (2003) (59)
- Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process. (2016) (57)
- Fibrinolysis in disseminated intravascular coagulation. (2001) (57)
- Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk (2015) (57)
- Nϵ-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? (2006) (55)
- Tissue factor pathway of coagulation in sepsis (2000) (53)
- Differential effects of donor‐specific HLA antibodies in living versus deceased donor transplant (2018) (53)
- Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. (2012) (52)
- PIRCHE-II Is Related to Graft Failure after Kidney Transplantation (2018) (51)
- Mechanisms of lymphocyte-mediated cytotoxicity in acute renal allograft rejection. (1998) (50)
- Target levels of functional C1‐inhibitor in hereditary angioedema (2012) (50)
- Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction. (1999) (47)
- Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy. (1998) (46)
- Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. (1994) (45)
- Intercellular Adhesion Molecule‐1 in the Heart (2002) (44)
- CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? (2001) (43)
- Antibodies against ARHGDIB are associated with long‐term kidney graft loss (2019) (42)
- Inhibition of sPLA2-IIA, C-reactive protein or complement: new therapy for patients with acute myocardial infarction? (2006) (41)
- Apoptotic tubular cell death during acute renal allograft rejection. (1998) (40)
- Thymic Stromal Lymphopoietin, a Novel Proinflammatory Mediator in Rheumatoid Arthritis That Potently Activates CD1c+ Myeloid Dendritic Cells to Attract and Stimulate T Cells (2014) (40)
- Inhibition of type 2A secretory phospholipase A2 reduces death of cardiomyocytes in acute myocardial infarction (2009) (39)
- CSF markers related to pathogenetic mechanisms in Alzheimer's disease (2002) (38)
- Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease (2008) (38)
- N(omega)-(carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels. (2004) (37)
- Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. (1999) (36)
- A modified competitive inhibition radioimmunoassay for the detection of C3a. Use of 125I-C3 instead of 125I-C3a. (1988) (35)
- Activated human PMN synthesize and release a strongly fucosylated glycoform of α1‐acid glycoprotein, which is transiently deposited in human myocardial infarction (2005) (35)
- Chronic idiopathic and secondary neutropenia: clinical and serological investigations (1986) (34)
- Interference of IgG, IgG aggregates and immune complexes in tests for platelet autoantibodies (1983) (34)
- Studies on the Contact System of Coagulation during Therapy with High Doses of Recombinant IL-2: Implications for Septic Shock (1991) (33)
- C‐reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion (2004) (33)
- Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3". (1990) (32)
- Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease. (1992) (32)
- Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase. (2010) (30)
- C-reactive protein and natural IgM antibodies are activators of complement in a rat model of intestinal ischemia and reperfusion. (2007) (30)
- Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis. (2015) (29)
- Activation of the contact system in insect-sting anaphylaxis: association with the development of angioedema and shock. (1993) (29)
- Leucocyte expression of complement C5a receptors exacerbates infarct size after myocardial reperfusion injury. (2014) (29)
- Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock. (1993) (29)
- Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema. (2017) (29)
- H9c2 cardiomyoblasts produce thyroid hormone. (2008) (28)
- Administration of OKT3 as a two-hour infusion attenuates first-dose side effects. (1997) (27)
- Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index values. (2011) (26)
- Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure. (2018) (26)
- Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. (1998) (25)
- Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival (2019) (25)
- Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients (2019) (25)
- Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation (2016) (24)
- Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. (2002) (23)
- Apolipoprotein H, a new mediator in the inflammatory changes ensuing in jeopardised human myocardium (2000) (23)
- A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation (2016) (23)
- Hereditary Angioedema Attacks: Local Swelling at Multiple Sites (2016) (23)
- C‐reactive protein levels in hereditary angioedema (2014) (23)
- Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients (2018) (22)
- Immunogenicity Assessment of Recombinant Human C1-Inhibitor (2012) (21)
- Activation of Coagulation and Fibrinolysis Following OKT3 Administration to Renal Transplant Recipients: Association with Distinct Mediators (1992) (21)
- Recombinant C1-Inhibitor (2012) (20)
- Clinical impact of peripheral attacks in hereditary angioedema patients. (2012) (19)
- The PROCARE consortium: toward an improved allocation strategy for kidney allografts. (2014) (19)
- IL4‐10 fusion protein: a novel immunoregulatory drug combining activities of interleukin 4 and interleukin 10 (2018) (19)
- Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies. (2012) (19)
- A fusion protein of interleukin‐4 and interleukin‐10 protects against blood‐induced cartilage damage in vitro and in vivo (2017) (17)
- Increased Nox 2 expression in human cardiomyocytes after acute myocardial infarction (2003) (17)
- A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival. (2018) (17)
- Intravenous immunoglobulins: a treatment for Alzheimer’s disease? (2004) (16)
- Secretory type II phospholipase A2 in culprit coronary lesions is associated with myocardial infarction (2008) (16)
- Immunosafety of Recombinant Human C1-Inhibitor in Hereditary Angioedema: Evaluation of IgE Antibodies (2013) (15)
- Evidence for bradykinin release in chronic spontaneous urticaria (2020) (13)
- C-reactive protein co-localizes with complement in human hearts during acute myocardial infarction (1996) (13)
- Thymic stromal lymphopoietin as a novel mediator amplifying immunopathology in rheumatic disease. (2015) (12)
- Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory study (2019) (12)
- Safety of C1-inhibitor for clinical use. (2002) (11)
- Derangements of coagulation and fibrinolysis in infectious diseases. (2003) (11)
- A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation (2019) (11)
- Role for complement as an intermediate between C-reactive protein and intercellular adhesion molecule-1 expression? (2001) (9)
- High occurrence of antihistamine resistance in patients with recurrent idiopathic angioedema (2019) (9)
- Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren’s syndrome is associated with increased disease activity (2016) (9)
- CSF levels of PSA and PSA–ACT complexes in Alzheimer's disease (2009) (8)
- Coagulation studies. (2001) (8)
- Toxicity of OKT 3 increases with dosage: a controlled study in renal transplant recipients (1995) (8)
- IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response. (2012) (8)
- Inhibition of type 2 A secretory phospholipase A 2 reduces death of cardiomyocytes in acute myocardial infarction (2009) (8)
- Thromboembolic complications and dose of monoclonal OKT3 antibody (1992) (8)
- Immunoglobulin M, C-Reactive Protein and Complement Activation in Rat Hepatic Ischemia-Reperfusion Injury (2014) (7)
- Pulmonary Secretory Phospholipase A2 in Infants with Respiratory Distress Syndrome Stimulates in vitro Neutrophil Migration (2009) (7)
- Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients. (2018) (7)
- Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis. (2014) (6)
- Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patients. (1996) (6)
- Pharmacokinetics of C1‐inhibitor protein in patients with acute myocardial infarction (2002) (6)
- Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis. (2020) (6)
- Toxicity of OKT3 increases with dosage: a controlled study in renal transplant recipients (1995) (6)
- The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade (2015) (6)
- C-reactive protein and cardiovascular disease: linked by complement? (2000) (6)
- H 9 c 2 cardiomyoblasts produce thyroid hormone (2008) (5)
- The Impact of Heparin Coated Circuits Upon Metabolism in Vital Organs: Effect Upon Cerebral and Renal Function During and After Cardiopulmonary Bypass (2005) (5)
- Biochemical diagnosis of Alzheimer's disease (2000) (5)
- Inflammatory markers in AD and MCI patients with different biomarker profiles—interpretation of serum and CSF levels (2010) (5)
- Co-localization of C-reactive protein and complement in human hearts during acute myocardial infarction (1997) (5)
- Clinical Studies of Recombinant Human C1 Inhibitor (rhC1INH) in Patients with Acute Attacks of Hereditary Angioedema (2008) (5)
- A fusion protein of interleukin-4 and interleukin-10 protects against blood-induced cartilage damage in vitro and in vivo (2016) (4)
- Selective expansion of a peripheral blood CD8+ memory T cell subset expressing both granzyme B and L-selectin during primary viral infection in renal allograft recipients. (1998) (4)
- Cytokines, coagulation and fibrinolysis (1999) (4)
- NAD(P)H oxidase in the failing human heart. (2003) (4)
- IL4-10 synerkine to induce direct and indirect structural cartilage repair in osteoarthritis (2015) (4)
- Activation of coagulation and fibrinolysis during treatment with OKT3. (1993) (3)
- Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation (2017) (3)
- Allergenicity and safety of recombinant human C1 esterase inhibitor in patients with allergy to rabbit or cow's milk. (2016) (3)
- The Autoimmune-Associated Single Nucleotide Polymorphism Within PTPN22 Correlates With Clinical Outcome After Lung Transplantation (2019) (3)
- Effects of divided doses of steroids on side effects, cytokines, and activation of complement and granulocytes, coagulation and fibrinolysis after OKT3. (1994) (3)
- Intentional diagnostic sting challenges: an important medical issue. (1994) (3)
- TSLP: a novel potent proinflammatory mediator that activates myeloid dendritic cells to stimulate Th1 and Th17 activity in rheumatoid arthritis (2011) (3)
- Detecting oral kallikrein-targeting therapy through triggered contact activation: a phase I study. (2020) (2)
- Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy (2021) (2)
- COMPLEMENT ACTIVATION IN CHILDREN WITH SEPTIC SHOCK AND PURPURA (SSP): CLASSICAL OR ALTERNATIVE PATHWAY.: 292 (1997) (2)
- Re: Pathways of complement activation in sepsis. (1994) (2)
- Increased levels of sTNF receptors following OKT3 treatment. (1994) (2)
- C1-inhibitor: antigenic and functional analysis. (2000) (2)
- C-reactive protein and the risk of cardiovascular mortality. (2003) (2)
- Targeting Complement in Rheumatoid Arthritis (2008) (2)
- The Coagulation System in Sepsis (2002) (1)
- [Pathogenesis of anaphylactic symptoms following an insect sting]. (1993) (1)
- Letter by Krijnen et al regarding article, "The sPLA2 Inhibition to Decrease Enzyme Release after Percutaneous Coronary Intervention (SPIDER-PCI) trial". (2011) (1)
- Immunisation of guinea-pigs with circulating immune complexes from patients with rheumatoid arthritis. (1984) (1)
- [Anaphylactic reactions following insect stings: clinical aspects, course and treatment]. (1994) (1)
- Alzheimer amyloid plaque associated cytokines increase C1R and cis, not C1-inhibitor, expression by human astrocytes and neuroblastoma cell lines in vitro (1998) (1)
- Association between a Single Donor TARC/CCL17 Promotor Polymorphism and Obstructive Chronic Lung Allograft Dysfunction after Lung Transplantation (2017) (1)
- Granzyme Activity in the Inflamed Lung Is (2000) (1)
- IL4-10 fusion protein as a disease modifying therapy for osteoarthritis evaluated in a rat groove model in vivo (2018) (1)
- The Regulation of C1 Activation and Its Role in Disease (2000) (1)
- C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms. (2002) (1)
- Hormones, growth factors and other humoral factors (2003) (1)
- Decreased expression of TSLP in labial salivary glands of patients with primary Sjögren’s syndrome is associated with local- and systemic disease parameters (2012) (1)
- Distribution pattern and functional state of α1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease (1991) (1)
- Neuroimmunological mechanisms in cerebral amyloid formation in Alzheimer's disease (1992) (1)
- Rat C-reactive protein can activate the complement system (2001) (1)
- Anti-inflammatory interventions: a promising pathophysiological approach in the treatment of acute myocardial infaction (2001) (0)
- Pharmacokinetics of C1-inhibitor in patients with acute myocardial infarction (2002) (0)
- CRP as risk factor for acute myocardial infarction: a causal relation? (1998) (0)
- Selecting Patients for Insect Venom Immunotherapy (1993) (0)
- Gene expression and biosynthesis of C1 inhibitor by primary human astrocytes (1997) (0)
- Soluble CD59 Is a Novel Biomarker for the Prediction of the Bronchiolitis Obliterans Syndrome After Lung Transplantation (2015) (0)
- A fusion protein comprising interleukin 4 and interleukin 10 (2012) (0)
- CRP mediates complement actiavation in human myocardial infarction (2000) (0)
- HUMAN C-REACTIVE PROTEIN BINDS TO MURINE APOPTOTIC CELLS WITHOUT ENHANCING INJURY IN IN A MURINE INTESTINAL ISCHEMIA-REPERFUSION MODEL 5 (2014) (0)
- Interleukin-6 predicts myocardial recovery (stunning) after acute myocardial infarction (1997) (0)
- Subject Index Vol. 26, 2008 (2008) (0)
- New developments concerning CSF markers in Alzheimer's disease (1991) (0)
- A fusion protein of IL4 and IL10 (IL4-10 synerkine), is very effective in protecting cartilage from blood-induced damage (2014) (0)
- Recombinant Human C1 Inhibitor Treatment Does Not Affect D-Dimer Levels and Is Not Associated With Thromboembolic Events In HAE Patients (2014) (0)
- Increased BACE1 activity in CSF of patients with an Alzheimer biomarker profile (2009) (0)
- C-reactive protein-mediated complement activation during acute myocardial infarction in humans (2002) (0)
- UvA-DARE (Digital Academic Repository) Epinephrine exerts anticoagulant effects during human endotoxemia (1997) (0)
- Proteinase Inhibitors Not Controlled by Endogenous Serine Granzyme Activity in the Inflamed Lung Is (2000) (0)
- CRP as a clinical marker of risk (2000) (0)
- DIFFERENTIAL EFFECT OF DONOR-SPECIFIC HLA ANTIBODIES IN LIVING VERSUS DECEASED DONOR KIDNEY TRANSPLANTATION (2017) (0)
- Contents Vol. 26, 2008 (2008) (0)
- Sepsis and Coagulation (1999) (0)
- A Single Donor TARC/CCL17 Promotor Polymorphism Correlates with Serum TARC/CCL17 Levels and Is Associated with Impaired Clinical Outcome after Lung Transplantation (2016) (0)
- P3-086: CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease (2008) (0)
- 39 THE COAGULATION SYSTEM IN SEPSIS C (0)
- CYTOKINE LEVELS IN MENINGOCOCCCAL SEPSIS: NOT ALL ARE RELATED WITH SURVIVAL (1999) (0)
- Globular Head Region Interacts with C-Reactive Protein through Its Evidence That Complement Protein C1q (2006) (0)
- Inflammatory markers as risk factor for the early stage (MCI) of Alzheimer's disease (2002) (0)
- CRP-mediated activation of complement in acute myocardial infarction: a novel target for therapy? (2001) (0)
- Complement activation during physical stress in hereditary angioedema patients (1993) (0)
- Complement Activation and Possible Therapeutic Interventions in Thermal Trauma: 127. (2000) (0)
- Interleukin-6 release predicts myocardial recovery (stunning) after acute myocardial infarction (1998) (0)
- Local and slow release of IL4-10 synerkine as a disease modifying therapy for osteoarthritis (2016) (0)
- CRP and cardiovascular disease: linked by complement? (2002) (0)
- During Human Endotoxemia Mitogen-Activated Protein Kinase Inhibitor Anti-Inflammatory Effects of a p38 (2002) (0)
- TIME COURSE OF IL‐10 AND IL‐12 IN CHILDREN WITH SEPTIC SHOCK AND PURPURA (SSP).: 560 (1997) (0)
- C-reactive proteinasa pro-inflammatory mediatorincardiovascular diseaseby its ability toactivatecomplement:additional proofand hypothetical mechanisms (2002) (0)
- Absence of complement factor c5a receptor on circulating cells reduces myocardial reperfusion injury and improves cardiac function (2013) (0)
- Role and regulation of early complement activation products in Alzheimer’s disease (2001) (0)
- Glucose-Insulin-K (GIK) in primary PTCA patients for infarct size reduction and improvement of perfusion (2002) (0)
- Consequences of OKT3 administration via continuous infusion as compared to bolus infusion. (1996) (0)
- Therapeutic proteins methods and protocols (2005) (0)
- 376 Increased Nox2 expression in human cardiomyocytes after AMI (2003) (0)
- Complement Activation by C-Reactive Protein: An Inflammatory Mechanism in Human Disease? (1999) (0)
- Inflammation and acute myocardial infarction (2007) (0)
- Decreased Graft Survival of Retransplants can Largely be Explained By Increased Hla-immunization (2018) (0)
- Release of interleukin-6 in acute myocardial infarction: apparent difference between myocardial necrosis and stunning (1997) (0)
- Complement c 3 activation in serum quantitative analysis of the generation of complement c 3a complement c 3b c and complement c 3d g as measured by specific radioimmunoassays (1985) (0)
- LEVELS OF APC, S‐PROTEIN C RECEPTOR AND THROMBOMODULIN IN MENINGOCOCCAL SEPTIC SHOCK ARE RELATED TO SURVIVAL.: 165 (2001) (0)
- Inflammation Related Factors: Role in Alzheimer’s Disease and Use as Biomarkers (2008) (0)
- Combination of coagulation factor viii with apc-resistant factor v (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Cornelis Erik Hack?
Cornelis Erik Hack is affiliated with the following schools:
